Valuation dashboard for Nuwellis, Inc. (NUWE) with P/E N/A, P/B -0.07, EV/EBITDA 0.50 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc.
Analysis Summary
Nuwellis, Inc. reported revenue of $8.3M in the most recent fiscal year, growing at a 5-year CAGR of 2.1%.
Trailing-twelve-month margins: gross margin 69.7%, operating margin -140.6%, net margin -123.4%.
At the current price of $0.81, NUWE has negative trailing earnings (P/E not meaningful) and an ROE of -6.06%. Market capitalisation stands at $0M.
Balance sheet quality for NUWE: current ratio of 1.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | -0.07 |
| EV / EBITDA | 0.50 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $2.18 |
| vs Current Price | +168.1% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| NUWE | Nuwellis, Inc. | -6.1% | |||
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 29.27 | 4.55 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $66.5B | 48.91 | 5.86 | 11.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $0.81 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -605.75% |
| Return on Invested Capital | -238.32% |
| Return on Assets | -121.85% |
| Gross Margin | 69.69% |
| Operating Margin | -140.62% |
| Net Margin | -123.38% |
Related companies: ACON · BACK · BCTXW · IVF · NUVO · OCEA · PETV
Explore sector: Healthcare · Medical - Devices
More sections of NUWE: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks